ADJUVANT THERAPY
Clinical trials for ADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug showdown: can it outperform standard pills to keep advanced throat cancer at bay?
Disease control Not yet recruitingThis study aims to see if a new intravenous drug, Becotatug Vedotin, works better than the standard oral chemotherapy (capecitabine) at preventing cancer from coming back in people with high-risk, advanced nasopharyngeal carcinoma (a type of throat cancer). It will involve about …
Matched conditions: ADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
AI vs. liver cancer: can computers pick who needs treatment?
Disease control Not yet recruitingThis study aims to see if an artificial intelligence (AI) model can better identify which liver cancer patients need immunotherapy after surgery to prevent the cancer from coming back. It will follow 300 patients who have had their liver tumors surgically removed. The AI will ana…
Matched conditions: ADJUVANT THERAPY
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC